Skip to main content

Table 1 Demographic data and stone parameters of the study groups

From: What is the safe and effective dilator number during access in PCNL? Three-shot dilation versus classical sequential Amplatz dilation

 

Demographic variables

 

3SD (n = 138)

SAD (n = 145)

p

Age (mean ± SD)

47.48 ± 13.25

47.16 ± 14.18

0.8441

BMI (kg/m2) (mean ± SD)

24.88 ± 2.97

24.47 ± 2.5

0.2061

Gender (n)

  

0.6062

 Male

101 (73.2%)

110 (75.9%)

 

 Female

37 (26.8%)

35 (24.1%)

 

Laterality (n)

  

0.8482

 Right

66 (47.83%)

71 (48.97%)

 

 Left

72 (52.17%)

74 (51.03%)

 

History of surgery (n)

  

0.6092

 Absent

116 (84.06%)

127 (87.59%)

 

 Open

8 (5.8%)

8 (5.52%)

 

 Endoscopic

14 (10.14%)

10 (6.9%)

 

ESWL (n)

44 (31.88%)

36 (24.83%)

0.1882

Stone location (n)

  

0.4302

 One calix

21 (15.22%)

19 (13.1%)

 

 Pelvic

37 (26.81%)

53 (36.55%)

 

 Multiple calyces

5 (3.62%)

7 (4.83%)

 

 Pelvic and calix

61 (44.2%)

52 (35.86%)

 

 Staghorn

14 (10.14%)

14 (9.66%)

 

Hydronephrosis grade (number)

  

0.5712

 No hydronephrosis

24 (17.39%)

22 (15.17%)

 

 Mild

71 (51.45%)

83 (57.24%)

 

 Moderate

34 (24.64%)

35 (24.14%)

 

 Severe

9 (6.52%)

5 (3.45%)

 

Stone burden, mm2 (mean ± SD) (median)

603.7 ± 543.55 (423)

578.99 ± 554.13 (423)

0.3993

Stone density in Hounsfield units (mean ± SD) (median)

1175.96 ± 363.94 (1171)

1216.83 ± 377.61 (1200)

0.5063

  1. 3SD Three-shot dilation, SAD Sequential Amplatz dilatation, SD Standard deviation, BMI Body mass index, ESWL Extracorporeal shock wave lithotripsy
  2. 1The Independent Samples t Test
  3. 2Chi-square test, 3Mann-Whitney U test